Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial (Q40714746)

23 September 2017

Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

23 September 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

7

Amirhossein Sahebkar

1 reference

23 September 2017

3

Gholamreza Askari

1 reference

23 September 2017

Sepideh Rahmani

1

1 reference

23 September 2017

Sedigheh Asgary

2

1 reference

23 September 2017

Mahtab Keshvari

4

1 reference

23 September 2017

Mahdi Hatamipour

5

1 reference

23 September 2017

Awat Feizi

6

1 reference

23 September 2017

8 June 2016

1 reference

23 September 2017

Phytotherapy Research

1 reference

23 September 2017

30

1 reference

23 September 2017

1540-1548

1 reference

23 September 2017

9

1 reference

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

23 September 2017

1 reference

Nonalcoholic fatty liver disease

21 January 2018

1 reference

The Effect of Symbiotic Supplementation on Liver Enzymes, C-reactive Protein and Ultrasound Findings in Patients with Non-alcoholic Fatty Liver Disease: A Clinical Trial

21 January 2018

1 reference

Fatty infiltration of liver in hyperlipidemic patients

21 January 2018

1 reference

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Curcumin extract for prevention of type 2 diabetes

21 January 2018

1 reference

Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial

21 January 2018

1 reference

Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people

21 January 2018

1 reference

Power and sample size calculations for studies involving linear regression.

21 January 2018

1 reference

Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice

21 January 2018

1 reference

Effect of curcumin on hepatic antioxidant enzymes activities and gene expressions in rats intoxicated with aflatoxin B1.

21 January 2018

1 reference

An investigation of the effects of curcumin on anxiety and depression in obese individuals: A randomized controlled trial

21 January 2018

1 reference

Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside

21 January 2018

1 reference

Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice

21 January 2018

1 reference

A Critical Approach to Evaluating Clinical Efficacy, Adverse Events and Drug Interactions of Herbal Remedies

21 January 2018

1 reference

Curcumin inhibits collagen synthesis and hepatic stellate cell activation in-vivo and in-vitro

21 January 2018

1 reference

Curcumin inhibits adipocyte differentiation through modulation of mitotic clonal expansion

21 January 2018

1 reference

Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells

21 January 2018

1 reference

Aldehyde Dehydrogenase-2 Roles in Ischemic Cardiovascular Disease

21 January 2018

1 reference

Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement

21 January 2018

1 reference

Investigation of the efficacy of adjunctive therapy with bioavailability-boosted curcuminoids in major depressive disorder.

21 January 2018

1 reference

Effects of Curcuminoids-Piperine Combination on Systemic Oxidative Stress, Clinical Symptoms and Quality of Life in Subjects with Chronic Pulmonary Complications Due to Sulfur Mustard: A Randomized Controlled Trial.

21 January 2018

1 reference

Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis

21 January 2018

1 reference

Lipid-modifying effects of adjunctive therapy with curcuminoids-piperine combination in patients with metabolic syndrome: results of a randomized controlled trial.

21 January 2018

1 reference

Curcumin Lowers Serum Lipids and Uric Acid in Subjects With Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial.

21 January 2018

1 reference

Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial

21 January 2018

1 reference

Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial.

21 January 2018

1 reference

A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications.

21 January 2018

1 reference

The Effect of Green Tea Extract Supplementation on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

MicroRNA 33 regulates glucose metabolism.

21 January 2018

1 reference

Pharmacological actions of curcumin in liver diseases or damage.

21 January 2018

1 reference

Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?

21 January 2018

1 reference

Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis

21 January 2018

1 reference

Recent advances in pharmacotherapy for hypertriglyceridemia

21 January 2018

1 reference

Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals

21 January 2018

1 reference

Therapeutic potential of curcumin in non-alcoholic steatohepatitis

21 January 2018

1 reference

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

21 January 2018

1 reference

Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase.

21 January 2018

1 reference

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

Effects of Curcuma longa (turmeric) on postprandial plasma glucose and insulin in healthy subjects

21 January 2018

1 reference

Molecular mechanisms of hypolipidemic effects of curcumin

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PTR.5659

1 reference

23 September 2017

1 reference